Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...

An expert has explained that if you take weight-loss drugs you might get 'Ozempic mouth', though it's not all bad.

The molecule is semaglutide, and it's sold under the name ... They are large molecule drugs, so complex in structure and must be administered by injection. Importantly, Novo Nordisk's and Lilly's ...

They are large molecule drugs, so complex in structure and must be administered ... Novo Nordisk offers a pill version of semaglutide, called Rybelsus, for type 2 diabetes, but it requires ...

Lilly markets its dual GIP and GLP-1 receptor agonist, tirzepatide, as Mounjaro for T2D and Zepbound for obesity, while Novo Nordisk markets its semaglutide drugs as Ozempic for T2D and Wegovy for ...

Shares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the ...

Ozempic, originally prescribed for type 2 diabetes, is now widely used off-label for weight loss, but rapid results can lead ...

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!